版本:
中国

BRIEF-Obseva SA announces completion of early stage trial evaluating endometriosis drug

June 7 Obseva sa-

* Obseva SA announces the completion of a phase 1 pk/pd clinical trial evaluating different doses of obe2109 and add-back therapy

* Obseva SA - all regimens in phase 1 pk/pd clinical trial were well-tolerated and no safety signal emerged Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐